Companies Dominating the Smart Asthma Monitoring Device Landscape
- Astellas Pharma Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Adherium Limited
- AstraZeneca Group
- Cohero Health, Inc.
- GlaxoSmithKline plc
- Aevice Health
- Vectura Group plc
- BioTelemetry, Inc.
- Health Care Originals Inc.
- Reciprocal Labs Corporation
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of smart asthma monitoring device is assessed at USD 2.11 billion.
The smart asthma monitoring device market size was over USD 1.47 billion in 2024 and is projected to reach USD 25.65 billion by 2037, witnessing around 24.6% CAGR during the forecast period i.e., between 2025-2037. The growing prevalence of asthma, backed by rapid urbanization will drive the market growth.
North America industry is likely to hold largest revenue share of 38% by 2037, driven by high incidence of asthma in developed nations.
The major players in the market are Astellas Pharma Inc., Adherium Limited, AstraZeneca Group, Cohero Health, Inc., GlaxoSmithKline plc, Aevice Health, Vectura Group plc, BioTelemetry, Inc., Health Care Originals Inc., Reciprocal Labs Corporation
